Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Caleb Alexander

Showing results (171-180 of 414) with videos related to

Pageof 42
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2025
Use of Statins for Primary Prevention Among Individuals With CKD in the United States: A Cross-Sectional, Time-Trend AnalysisOshozimhede E Iyalomhe, Amarasinghe Arachchige Don Nalin Samandika Saparamadu, G Caleb Alexander
Drug and Alcohol Dependence|December 14, 2020
Estimating the prevalence of and characteristics associated with prescription opioid diversion among a clinic population living with HIV: Indirect and direct questioning techniquesChelsea E Canan, Geetanjali Chander, Richard Moore, et al.
Therapeutic Innovation & Regulatory Science|December 5, 2018
Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016G Caleb Alexander, Ken Ogasawara, Dana Wiegand, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 29, 2020
Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim ProductsMorgane C Mouslim, Antonio J Trujillo, G Caleb Alexander, et al.
Pharmacoepidemiology and Drug Safety|March 1, 2018
Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysisHsien-Yen Chang, Irene Murimi, Mark Faul, et al.
Health Affairs (Project Hope)|May 5, 2025
Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014-23Jenny S Guadamuz, G Caleb Alexander, Genevieve P Kanter, et al.
Journal of the American Geriatrics Society|February 18, 2010
Physicians' views on the importance of patient preferences in surrogate decision-makingAlexia M Torke, Rachael Moloney, Mark Siegler, et al.
Addiction (Abingdon, England)|December 2, 2017
Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribersHsien-Yen Chang, Irene B Murimi, Christopher M Jones, et al.
Plos One|April 19, 2018
Efficacy and safety of biosimilar insulins compared to their reference products: A systematic reviewCarolyn Tieu, Eleanor J Lucas, Mindi DePaola, et al.
JAMA Pediatrics|June 19, 2018
Prevalence of Dietary Supplement Use in US Children and Adolescents, 2003-2014Dima M Qato, G Caleb Alexander, Jenny S Guadamuz, et al.
Pageof 42

Showing results (171-180 of 414) with videos related to

Sort By:
Pageof 42
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2025
Use of Statins for Primary Prevention Among Individuals With CKD in the United States: A Cross-Sectional, Time-Trend AnalysisOshozimhede E Iyalomhe, Amarasinghe Arachchige Don Nalin Samandika Saparamadu, G Caleb Alexander
Drug and Alcohol Dependence|December 14, 2020
Estimating the prevalence of and characteristics associated with prescription opioid diversion among a clinic population living with HIV: Indirect and direct questioning techniquesChelsea E Canan, Geetanjali Chander, Richard Moore, et al.
Therapeutic Innovation & Regulatory Science|December 5, 2018
Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016G Caleb Alexander, Ken Ogasawara, Dana Wiegand, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 29, 2020
Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim ProductsMorgane C Mouslim, Antonio J Trujillo, G Caleb Alexander, et al.
Pharmacoepidemiology and Drug Safety|March 1, 2018
Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysisHsien-Yen Chang, Irene Murimi, Mark Faul, et al.
Health Affairs (Project Hope)|May 5, 2025
Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014-23Jenny S Guadamuz, G Caleb Alexander, Genevieve P Kanter, et al.
Journal of the American Geriatrics Society|February 18, 2010
Physicians' views on the importance of patient preferences in surrogate decision-makingAlexia M Torke, Rachael Moloney, Mark Siegler, et al.
Addiction (Abingdon, England)|December 2, 2017
Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribersHsien-Yen Chang, Irene B Murimi, Christopher M Jones, et al.
Plos One|April 19, 2018
Efficacy and safety of biosimilar insulins compared to their reference products: A systematic reviewCarolyn Tieu, Eleanor J Lucas, Mindi DePaola, et al.
JAMA Pediatrics|June 19, 2018
Prevalence of Dietary Supplement Use in US Children and Adolescents, 2003-2014Dima M Qato, G Caleb Alexander, Jenny S Guadamuz, et al.
Pageof 42